Colombia at the centre of preclinical AD research.
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000235:genetics*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D035843:Biomedical Research / Q000458:organization & administration; D002986:Clinical Trials as Topic; D003105:Colombia; D006801:Humans; D053763:Presenilins / Q000235:genetics*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D053763:Presenilins; C573372:crenezumab